Table 2

Risk stratification for discontinuation of clopidogrel, prasugrel or ticagrelor based on the risk of thrombosis

High riskLow risk
Drug eluting coronary artery stents within 12 months of placementIschaemic heart disease without coronary stents
Bare metal coronary artery stents within 1 month of placementCerebrovascular disease
Peripheral vascular disease